Skip to main content

Table 2 Comparison of Age and Urinary Proteins Between PCa and BPH Cohorts

From: Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer

Variable

PCa

BPH

  
 

(N = 90)

(N = 83)

AUC

P value

Age, years, mean

63.3 ± 8.7

66.1 ± 8.4

–

0.15

β2M

143.4 (44.5-289.8)

30.3 (4.2-194.6)

0.658

<0.001*

PGA3

198 (32–329)

106 (8–263)

0.623

0.006*

MUC3 25 kDa

421 (239–490)

322 (93–465)

0.605

0.018*

MUC3 51 kDa

33.0 (6.3-104.9)

18.7 (3.2-68.4)

0.583

0.06

APOD

381 (134–512)

255 (35–486)

0.568

0.14

THP

267 (122–368)

232 (89–377)

0.547

0.30

ZAG

384 (144–529)

351 (89–523)

0.522

0.64

  1. Biomarker data are median (interquartile range) of densitometric units (DU). AUC = area under the curve. * Statistically significant.